150 related articles for article (PubMed ID: 20471479)
1. Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats.
Cruz L; Assumpção E; Andrade SF; Conrado DJ; Kulkamp IC; Guterres SS; Pohlmann AR
Eur J Pharm Sci; 2010 Aug; 40(5):441-7. PubMed ID: 20471479
[TBL] [Abstract][Full Text] [Related]
2. Microencapsulation of sodium alendronate reduces drug mucosal damage in rats.
Cruz L; Assumpção E; Andrade SF; Conrado DJ; Guterres SS; Pohlmann AR
Drug Deliv; 2010 May; 17(4):231-7. PubMed ID: 20196631
[TBL] [Abstract][Full Text] [Related]
3. Alendronate-loaded microparticles for improvement of intestinal cellular absorption.
Baek JS; Kwon HH; Hwang JS; Sung HC; Lee JM; Shin SC; Kim YR; Cho CW
J Drug Target; 2011 Jan; 19(1):37-48. PubMed ID: 20477555
[TBL] [Abstract][Full Text] [Related]
4. Effect of concurrent administration of alendronate sodium and retinol on development of changes in histomorphometric parameters of bones induced by ovariectomy in rats.
Pytlik M; Kaczmarczyk-Sedlak I; Sliwiński L; Janiec W; Rymkiewicz I
Pol J Pharmacol; 2004; 56(5):571-9. PubMed ID: 15591645
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterisation of alendronate-loaded chitosan microparticles obtained through the spray drying technique.
Ochiuz L; Peris JE
Med Chem; 2009 Mar; 5(2):191-6. PubMed ID: 19275718
[TBL] [Abstract][Full Text] [Related]
6. Effect of administration of alendronate sodium and retinol on the mechanical properties of the femur in ovariectomized rats.
Sliwiński L; Janiec W; Pytlik M; Folwarczna J; Kaczmarczyk-Sedlak I; Pytlik W; Cegieła U; Nowińska B
Pol J Pharmacol; 2004; 56(6):817-24. PubMed ID: 15662095
[TBL] [Abstract][Full Text] [Related]
7. Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting.
Nasr M; Awad GA; Mansour S; Taha I; Al Shamy A; Mortada ND
Eur J Pharm Biopharm; 2011 Nov; 79(3):601-11. PubMed ID: 21827854
[TBL] [Abstract][Full Text] [Related]
8. In situ fabrication of alendronate-loaded calcium phosphate microspheres: controlled release for inhibition of osteoclastogenesis.
Kim CW; Yun YP; Lee HJ; Hwang YS; Kwon IK; Lee SC
J Control Release; 2010 Oct; 147(1):45-53. PubMed ID: 20600398
[TBL] [Abstract][Full Text] [Related]
9. Preparation of an injectable depot system for long-term delivery of alendronate and evaluation of its anti-osteoporotic effect in an ovariectomized rat model.
Bae J; Park JW
Int J Pharm; 2015 Mar; 480(1-2):37-47. PubMed ID: 25595570
[TBL] [Abstract][Full Text] [Related]
10. Formulation and in vivo evaluation of sodium alendronate spray-dried microparticles intended for lung delivery.
Cruz L; Fattal E; Tasso L; Freitas GC; Carregaro AB; Guterres SS; Pohlmann AR; Tsapis N
J Control Release; 2011 Jun; 152(3):370-5. PubMed ID: 21396412
[TBL] [Abstract][Full Text] [Related]
11. Colon-targeted celecoxib-loaded Eudragit® S100-coated poly-ε-caprolactone microparticles: preparation, characterization and in vivo evaluation in rats.
Ghorab DM; Amin MM; Khowessah OM; Tadros MI
Drug Deliv; 2011; 18(7):523-35. PubMed ID: 21793779
[TBL] [Abstract][Full Text] [Related]
12. Alginate microspheres of isoniazid for oral sustained drug delivery.
Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
[TBL] [Abstract][Full Text] [Related]
14. Inhalation of alendronate nanoparticles as dry powder inhaler for the treatment of osteoporosis.
Sultana S; Talegaonkar S; Ali R; Mittal G; Ahmad FJ; Bhatnagar A
J Microencapsul; 2012; 29(5):445-54. PubMed ID: 22292965
[TBL] [Abstract][Full Text] [Related]
15. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles.
Cohen-Sela E; Chorny M; Koroukhov N; Danenberg HD; Golomb G
J Control Release; 2009 Jan; 133(2):90-5. PubMed ID: 18848962
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats.
Otsuka M; Uenodan H; Matsuda Y; Mogi T; Ohshima H; Makino K
Biomed Mater Eng; 2002; 12(2):157-67. PubMed ID: 12122239
[TBL] [Abstract][Full Text] [Related]
17. Absorption and safety of alendronate, a nitrogen-containing bisphosphonate, after intrapulmonary administration in rats.
Katsumi H; Nakatani M; Sano J; Abe M; Kusamori K; Kurihara M; Shiota R; Takashima M; Fujita T; Sakane T; Hibi T; Yamamoto A
Int J Pharm; 2010 Nov; 400(1-2):124-30. PubMed ID: 20816731
[TBL] [Abstract][Full Text] [Related]
18. Sol-gel derived titania coating with immobilized bisphosphonate enhances screw fixation in rat tibia.
Linderbäck P; Areva S; Aspenberg P; Tengvall P
J Biomed Mater Res A; 2010 Aug; 94(2):389-95. PubMed ID: 20186735
[TBL] [Abstract][Full Text] [Related]
19. [The treatment of osteoporosis and bone resorption of alveoli with alendronate in rat model].
Wang X; Yang Z; Yu S
Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 May; 36(3):193-6. PubMed ID: 11812340
[TBL] [Abstract][Full Text] [Related]
20. Influence of estrogen deficiency and its treatment with alendronate and estrogen on bone density around osseointegrated implants: radiographic study in female rats.
Giro G; Gonçalves D; Sakakura CE; Pereira RM; Marcantonio Júnior E; Orrico SR
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Feb; 105(2):162-7. PubMed ID: 18230387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
